Dimensional Fund Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.2M | Buy |
|
|||||
|
2025
Q1 | $95.1M | Buy |
|
|||||
|
2024
Q4 | $104M | Sell |
|
|||||
|
2024
Q3 | $89.9M | Buy |
|
|||||
|
2024
Q2 | $76.7M | Buy |
|
|||||
|
2024
Q1 | $87.2M | Buy |
|
|||||
|
2023
Q4 | $71.1M | Buy |
|
|||||
|
2023
Q3 | $63.8M | Sell |
|
|||||
|
2023
Q2 | $73.1M | Buy |
|
|||||
|
2023
Q1 | $86.6M | Buy |
|
|||||
|
2022
Q4 | $85K | Buy |
|
|||||
|
2022
Q3 | $76.9M | Buy |
|
|||||
|
2022
Q2 | $64.8M | Buy |
|
|||||
|
2022
Q1 | $71.8M | Sell |
|
|||||
|
2021
Q4 | $65.3M | Sell |
|
|||||
|
2021
Q3 | $60.7M | Sell |
|
|||||
|
2021
Q2 | $70.1M | Buy |
|
|||||
|
2021
Q1 | $55.8M | Buy |
|
|||||
|
2020
Q4 | $48.7M | Sell |
|
|||||
|
2020
Q3 | $40.9M | Buy |
|
|||||
|
2020
Q2 | $46.5M | Buy |
|
|||||
|
2020
Q1 | $32.7M | Buy |
|
|||||
|
2019
Q4 | $39.4M | Buy |
|
|||||
|
2019
Q3 | $44M | Buy |
|
|||||
|
2019
Q2 | $47.7M | Buy |
|
|||||
|
2019
Q1 | $48.3M | Buy |
|
|||||
|
2018
Q4 | $43.6M | Sell |
|
|||||
|
2018
Q3 | $67.2M | Sell |
|
|||||
|
2018
Q2 | $80.8M | Sell |
|
|||||
|
2018
Q1 | $64.3M | Buy |
|
|||||
|
2017
Q4 | $55.8M | Buy |
|
|||||
|
2017
Q3 | $50.7M | Sell |
|
|||||
|
2017
Q2 | $54.7M | Buy |
|
|||||
|
2017
Q1 | $35.9M | Buy |
|
|||||
|
2016
Q4 | $28M | Buy |
|
|||||
|
2016
Q3 | $26.1M | Buy |
|
|||||
|
2016
Q2 | $21.2M | Sell |
|
|||||
|
2016
Q1 | $16M | Sell |
|
|||||
|
2015
Q4 | $14.6M | Buy |
|
|||||
|
2015
Q3 | $13.6M | Buy |
|
|||||
|
2015
Q2 | $8.56M | Buy |
|